Oxidative imbalance in low/intermediate-1-risk myelodysplastic syndrome patients: The influence of iron overload


Por: Ivars D, Orero MT, Javier K, Díaz-Vico L, García-Giménez JL, Mena S, Tormos C, Egea M, Pérez PL, Arrizabalaga B, Ruiz MÁ, Yagüe N, Tormo M, Sancho-Tello R, Gomes A, Algueró C, O'Connor JE, Sáez GT, Carbonell F and Collado R

Publicada: 1 nov 2017 Ahead of Print: 29 may 2017
Resumen:
Objective: To assess the generation of reactive oxygen species (ROS) and the involvement of the main antioxidant pathways in low/intermediate-1-risk myelodysplastic syndromes (MDS) with iron overload (IOL). Methods: We examined the levels of superoxide anion (O-2 center dot(-)), hydrogen peroxide (H2O2), antioxidants (glutathione, GSH; superoxide dismutase, SOD; catalase, CAT; and glutathione peroxidase, GPx), mitochondrial membrane potential (Delta Psi m), and by-products of oxidative damage (8-isoprostanes and 8-oxo-7,8-dihydro-2'-deoxyguanosine, 8-oxo-dG) in 42 MDS patients (28 without IOL at diagnosis, and 14 who developed IOL) and 20 healthy subjects. Results: Patients with IOL showed higher O-2 center dot(-) levels (39.4 MFI) than normal controls (22.7 MFI, p = 0.0356) and patients at diagnosis (19.4 MFI, p = 0.0049). Antioxidant systems, except SOD activity, exhibited significant changes in IOL patients with respect to controls (CAT: 7.1 vs 2.7 nmol/ml/min, p = 0.0023; GPx: 50.9 vs 76.4 nmol/ml/min, p = 0.0291; GSH: 50.2 vs 24.1 MFI, p = 0.0060). Furthermore, mitochondrial dysfunction was only detected in IOL cases compared to controls (Delta Psi m: 3.6 vs 6.4 MFI, p = 0.0225). Finally, increased levels of 8-oxo-dG were detected in both groups of patients. Conclusion: Oxidative stress is an important but non-static phenomenon in MDS disease, whose status is influenced by, among other factors, the presence of injurious iron.

Filiaciones:
:
 Department of Medicine, Universitat de València, Av. Blasco Ibáñez 15, 46010, Valencia, Spain

 Service of Haematology, Hospital General Universitario de Valencia, Av. Tres Cruces 2, 46014, Valencia, Spain.

Orero MT:
 Service of Haematology, Hospital General Universitario de Valencia, Av. Tres Cruces 2, 46014, Valencia, Spain

Javier K:
 Service of Haematology, Hospital General Universitario de Valencia, Av. Tres Cruces 2, 46014, Valencia, Spain

Díaz-Vico L:
 Department of Biochemistry, Universitat de València, Av. Blasco Ibáñez 15, 46010, Valencia, Spain

García-Giménez JL:
 CIBERER, The Biomedical Network Research Centre on Rare Diseases, Calle Álvaro de Bazán 10, 46010, Valencia, Spain

Mena S:
 Department of Physiology, Universitat de València, Av. Blasco Ibáñez 15, 46010, Valencia, Spain

Tormos C:
 Department of Biochemistry, Universitat de València, Av. Blasco Ibáñez 15, 46010, Valencia, Spain

Egea M:
 Service of Haematology, Hospital General Universitario de Valencia, Av. Tres Cruces 2, 46014, Valencia, Spain

Pérez PL:
 Service of Haematology, Hospital General Universitario de Valencia, Av. Tres Cruces 2, 46014, Valencia, Spain

Arrizabalaga B:
 Service of Haematology, Hospital Universitario de Cruces, Plaza de Cruces 12, 48903 Barakaldo, Vizcaya, Spain

:
 Service of Haematology, Hospital Francesc de Borja, Av. Medicina 6, 46702 Gandía, Valencia, Spain

:
 Service of Haematology, Hospital Francesc de Borja, Av. Medicina 6, 46702 Gandía, Valencia, Spain

Tormo M:
 Service of Haematology, Hospital Clínico Universitario, Av. Blasco Ibáñez 17, 46010, Valencia, Spain

:
 Service of Haematology, Hospital Arnau de Vilanova, Calle Sant Clement 12, 46015, Valencia, Spain

Gomes A:
 Department of Biochemistry, Universitat de València, Av. Blasco Ibáñez 15, 46010, Valencia, Spain

Algueró C:
 Department of Biochemistry, Universitat de València, Av. Blasco Ibáñez 15, 46010, Valencia, Spain

O'Connor JE:
 Department of Biochemistry, Universitat de València, Av. Blasco Ibáñez 15, 46010, Valencia, Spain

:
 Service of Clinical Analyses, Hospital Universitario Doctor Peset, Av. Gaspar Aguilar 90, 46017, Valencia, Spain

Carbonell F:
 Department of Medicine, Universitat de València, Av. Blasco Ibáñez 15, 46010, Valencia, Spain

 Service of Haematology, Hospital General Universitario de Valencia, Av. Tres Cruces 2, 46014, Valencia, Spain

Collado R:
 Service of Haematology, Hospital General Universitario de Valencia, Av. Tres Cruces 2, 46014, Valencia, Spain
ISSN: 00099120





CLINICAL BIOCHEMISTRY
Editorial
PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND, Estados Unidos America
Tipo de documento: Article
Volumen: 50 Número: 16-17
Páginas: 911-917
WOS Id: 000413397200004
ID de PubMed: 28571970

MÉTRICAS